These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20512194)

  • 1. Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT.
    Cochet A; Berriolo-Riedinger A; Girault S; Rousseau C; Brunotte F; Couturier O
    Nuklearmedizin; 2009; 48(5):N45-6. PubMed ID: 20512194
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM; Tam SL; Kurland BF; Gralow JR; Livingston RB; Linden HM; Ellis GK; Schubert EK; Dunnwald LK; Mankoff DA
    Breast Cancer Res Treat; 2007 Sep; 105(1):87-94. PubMed ID: 17268819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and bone metastases.
    Fogelman I; Cook G; Israel O; Van der Wall H
    Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computer tomography in bone metastases].
    Skjłdt T; Svendsen J; Bertelsen V
    Rontgenblatter; 1985 Nov; 38(11):342-4. PubMed ID: 3001916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer: role of SPECT and PET in imaging bone metastases.
    Ben-Haim S; Israel O
    Semin Nucl Med; 2009 Nov; 39(6):408-15. PubMed ID: 19801220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
    Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P
    Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
    Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
    Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovations in breast cancer imaging: PET for diagnosis and follow-up.
    Adler LP; Bakale G; Schnur KC; Shenk RR
    Medscape Womens Health; 1998 Nov; 3(6):5. PubMed ID: 9878927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
    Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
    Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
    Hama Y
    Clin Nucl Med; 2014 Apr; 39(4):e290-1. PubMed ID: 23917785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluoride-positron emission tomography/computed tomography for differential diagnosis in suspected bone metastasis].
    Petersen H; Ogren M; Høilund-Carlsen PF
    Ugeskr Laeger; 2010 May; 172(20):1538-9. PubMed ID: 20483103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study.
    Contractor K; Aboagye EO; Jacob J; Challapalli A; Coombes RC; Stebbing J
    Biomark Med; 2012 Apr; 6(2):231-3. PubMed ID: 22448798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of bone metastases in breast cancer by positron emission tomography.
    Schirrmeister H
    Radiol Clin North Am; 2007 Jul; 45(4):669-76, vi. PubMed ID: 17706531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is baseline bone imaging in high-risk breast cancer patients justified?
    Ampil FL; Li BD; Burton GV; Kim RH; Baluna RG; Chu Q
    Breast J; 2012; 18(6):639-40. PubMed ID: 23009654
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.
    Basu S; Alavi A
    J Clin Oncol; 2007 Apr; 25(10):1297; author reply 1297-9. PubMed ID: 17401027
    [No Abstract]   [Full Text] [Related]  

  • 19. [CT findings of bone metastasis].
    Nosaki T; Murai T; Okumura A; Furuki T; Mori K; Tsuji S; Nakanishi K; Kobayashi M; Fukui A; Fujii K
    Rinsho Hoshasen; 1989 Sep; 34(9):991-7. PubMed ID: 2810844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/CT for monitoring therapy response in breast cancer patients with bone metastases.
    Beheshti M; Langsteger W
    Radiology; 2008 Oct; 249(1):389-90; author reply 390. PubMed ID: 18796691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.